Results 111 to 120 of about 19,421 (203)

Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy

, 2004
In the Declaration of Commitment endorsed during its June 2001 Special Session on HIV/AIDS, the United Nations General Assembly linked the prevention of mother-to-child transmission of the human immunodeficiency virus (HIV) with antiretroviral treatment ...
Lallemant, Marc, Bowonwatanuwong, Chureeratana, Hammer, S., Hammer, Scott, Jourdain, Gonzague, Leenasirimakul, P., Kantipong, P., Bowonwatanuwong, C., Ngo-Giang-Huong, Nicole, Le Coeur, Sophie, Leenasirimakul, Prattana, Leechnanachai, P., Kantipong, Pacharee, Ariyadej, S., Leechanachai, Pranee, Ariyadej, Surabhon   +15 more
core   +1 more source

Outcomes and safety of concomitant nevirapine and rifampicin treatment under programme conditions in Malawi.

, 2010
SETTING: Thyolo District Hospital, rural Malawi. OBJECTIVES: To report on 1) clinical, immunological and virological outcomes and 2) safety among human immunodeficiency virus (HIV) infected patients with tuberculosis (TB) who received concurrent ...
Zachariah, R, Misinde, D, Tayler-Smith, K, Manzi, M, Harries, AD, Foncha, C, Moses, M, Bauerfeind, A, Harries, A D, Mwagomba, B, Kwanjana, J   +10 more
core  

Antiretroviral treatment for children with peripartum nevirapine exposure

, 2010
Background: Single-dose nevirapine is the cornerstone of the regimen for prevention of mother-to-child transmission of human immunodeficiency virus (HIV) in resource-limited settings, but nevirapine frequently selects for resistant virus in mothers and ...
Lynette Purdue, Mutsawashe Bwakura-Dangarembizi, Musoke, P., Purdue, L., Eshleman, S. H., Tammy Meyers, Paul Palumbo, Patrick Jean-Philippe, Kamthunzi, P., Schimana, W., Cotton, M. F., Linda Millar, Mofenson, L. M., Benjamin H. Chi, Raziya Bobat, Meyers, T., Werner Schimana, Portia Kamthunzi, Abrams, E. J., Lindsey, J. C., Petzold, E., Lynne M. Mofenson, Bwakura-Dangarembizi, M., Mark F. Cotton, Chi, B. H., Elaine J. Abrams, Millar, L., Elizabeth Petzold, Jane C. Lindsey, Jean-Philippe, P., Avy Violari, Hughes, M. D., Palumbo, P., Philippa Musoke, Michael D. Hughes, Violari A., Susan H. Eshleman, Bobat, R.   +37 more
core   +1 more source

Pseudopolymorphs and Intrinsic Dissolution of Nevirapine

, 2016
Nevirapine (C15H14N4O) is a lipophilic drug of low aqueous solubility used in AIDS treatment. Three different crystal forms of this non-nucleoside reverse transcriptase inhibitor were obtained after recrystallization procedures. Physical characterization
Fabio D. Fonte-Boa (2474035), Cristina D. Vianna-Soares (2474029), Carlos B. Pinheiro (1411072), Bruno G. Pereira (2474032), Nelson G. Fernandes (2474038), Maria I. Yoshida (621914), Jackson A. L. C. Resende (1492786)   +6 more
core   +1 more source

The role of CYP3A in nevirapine induced hepatotoxicity

, 2003
Nevirapine is a potent non-nucleoside reverse transcriptase inhibitor with favourable pharmacokinetics that are characterised by rapid absorption and distribution with a long elimination half-life.
Barr, Shera
core  

HLA-dependent hypersensitivity to nevirapine in Sardinian HIV patients

, 2006
Background: Hypersensitivity reaction to nevirapine, which in some cases can be fatal, shows a higher prevalence in Sardinia in comparison with other Italian regions.
Piano, P, Littera, R, Ortu, F, Casula, B, MANCONI, PAOLO EMILIO, Contu, L, Corso, N, CARCASSI, CARLO, LA NASA, GIORGIO, Masala, A, Serra, P   +10 more
core   +1 more source

Plasma lipid profile in pregnant women with HIV receiving nevirapine

, 2009
Limited information is currently available on the metabolic profile of nevirapine in pregnancy. We used data from a national observational study to evaluate plasma lipid profile in pregnant women receiving nevirapine.
MASSETTI, Anna Paola, Gianfranco Anzidei, Brunella Guerra, Marina Ravizza, Atim Molinari, Marco Floridia, G. Anzidei, Enrica Tamburrini, Alessandra Meloni, Italian Group, E. Tamburrini, ANCESCHI, Maurizio Marco, Serena Dalzero, M. Floridia, A. Vimercati, C. Pinnetti, S. Dalzero, Carmela Pinnetti, Antonella Vimercati, B. Guerra, Cecilia Tibaldi, A. M. Meloni, A. Molinari, G. Guaraldi, C. Tibaldi, M. Ravizza, Giovanni Guaraldi   +26 more
core   +1 more source

Addition of 7 Days of Zidovudine Plus Lamivudine to Peripartum Single-Dose Nevirapine Effectively Reduces Nevirapine Resistance Postpartum in HIV-Infected Mothers in Malawi

, 2010
We assessed whether 7 days of zidovudine+lamivudine postpartum with single-dose nevirapine at labor decreases nevirapine resistance in HIV-infected women in ...
van der Horst, Charles, Jamieson, Denise J, Chasela, Charles, Matiki, Chrissie, Ngʼombe, Thokozani J, Tegha, Gerald L, Kourtis, Athena P, Kashuba, Angela D M, Farr, Sherry L, Johnson, Jeffrey A, Banda, Harriet N, Nelson, Julie A E, Wiener, Jeffrey, Lipscomb, Jonathan, Fiscus, Susan A, Mpaso, Mwanangwa, Eron, Joseph J   +16 more
core   +1 more source

Nevirapine induced Stevens-Johnson syndrome in an HIV infected patient

, 2011
Nevirapine, a non-nucleoside reverse transcriptase inhibitor (NNRTI), is widely prescribed as a part of the combination therapy of human immunodeficiency virus (HIV) infection because of its efficacy and good tolerability.
Singh, Harminder, Nayak, Kalpana, Kumar, Bithika Nel, Kachhap, Vinay Kumar   +3 more
core  

Cost-effectiveness of childbirth strategies for prevention of mother-to-child transmission of HIV among mothers receiving nevirapine in India

Indian Journal of Community Medicine, 2010
Background: Mother-to-child transmission of HIV is an important mode of spread of HIV in India. With strategies like caesarian section and nevirapine therapy, this spread has been reduced. However, they have costs attached.
Mukherjee Kanchan
doaj